GSK faces Senator probe for pulling asthma inhaler in U.S.

Magdalena Wygralak

Democratic U.S. Senator Maggie Hassan has reportedly launched an investigation into British pharmaceutical giant GSK's (NYSE:GSK) decision to pull the branded Flovent HFA asthma inhaler from the U.S. market early last year.

Hassan, a member of the Senate Committee on Health, Education, Labor, and